These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 18376369)

  • 1. Hepatic expression of ghrelin and adiponectin and their receptors in patients with nonalcoholic fatty liver disease.
    Uribe M; Zamora-Valdés D; Moreno-Portillo M; Bermejo-Martínez L; Pichardo-Bahena R; Baptista-González HA; Ponciano-Rodríguez G; Uribe MH; Medina-Santillán R; Méndez-Sánchez N
    Ann Hepatol; 2008; 7(1):67-71. PubMed ID: 18376369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum adipokine levels predictive of liver injury in non-alcoholic fatty liver disease.
    Lemoine M; Ratziu V; Kim M; Maachi M; Wendum D; Paye F; Bastard JP; Poupon R; Housset C; Capeau J; Serfaty L
    Liver Int; 2009 Oct; 29(9):1431-8. PubMed ID: 19422483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How adiponectin, leptin, and ghrelin orchestrate together and correlate with the severity of nonalcoholic fatty liver disease.
    Machado MV; Coutinho J; Carepa F; Costa A; Proença H; Cortez-Pinto H
    Eur J Gastroenterol Hepatol; 2012 Oct; 24(10):1166-72. PubMed ID: 22735605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pattern of expression of adiponectin receptors in human liver and its relation to nonalcoholic steatohepatitis.
    Nannipieri M; Cecchetti F; Anselmino M; Mancini E; Marchetti G; Bonotti A; Baldi S; Solito B; Giannetti M; Pinchera A; Santini F; Ferrannini E
    Obes Surg; 2009 Apr; 19(4):467-74. PubMed ID: 18923878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of synthesis and oxidation of fatty acids by adiponectin receptors (AdipoR1/R2) and insulin receptor substrate isoforms (IRS-1/-2) of the liver in a nonalcoholic steatohepatitis animal model.
    Matsunami T; Sato Y; Ariga S; Sato T; Shimomura T; Kashimura H; Hasegawa Y; Yukawa M
    Metabolism; 2011 Jun; 60(6):805-14. PubMed ID: 20846698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Free fatty acids repress small heterodimer partner (SHP) activation and adiponectin counteracts bile acid-induced liver injury in superobese patients with nonalcoholic steatohepatitis.
    Bechmann LP; Kocabayoglu P; Sowa JP; Sydor S; Best J; Schlattjan M; Beilfuss A; Schmitt J; Hannivoort RA; Kilicarslan A; Rust C; Berr F; Tschopp O; Gerken G; Friedman SL; Geier A; Canbay A
    Hepatology; 2013 Apr; 57(4):1394-406. PubMed ID: 23299969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adipocytokines and cytokeratin-18 in patients with nonalcoholic fatty liver disease: Introduction of CHA index.
    Polyzos SA; Kountouras J; Papatheodorou A; Katsiki E; Patsiaoura K; Zafeiriadou E; Papadopoulou E; Zavos C; Terpos E
    Ann Hepatol; 2013; 12(5):749-57. PubMed ID: 24067262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a low-fat diet on the hepatic expression of adiponectin and its receptors in rats with NAFLD.
    Ma H; You GP; Cui F; Chen LF; Yang XJ; Chen LG; Lu HD; Zhang WQ
    Ann Hepatol; 2015; 14(1):108-17. PubMed ID: 25536648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis.
    Wieckowska A; Papouchado BG; Li Z; Lopez R; Zein NN; Feldstein AE
    Am J Gastroenterol; 2008 Jun; 103(6):1372-9. PubMed ID: 18510618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obestatin protects and reverses nonalcoholic fatty liver disease and its associated insulin resistance in rats via inhibition of food intake, enhancing hepatic adiponectin signaling, and blocking ghrelin acylation.
    Khaleel EF; Abdel-Aleem GA
    Arch Physiol Biochem; 2019 Feb; 125(1):64-78. PubMed ID: 29429367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum adiponectin levels in different types of non alcoholic liver disease. Correlation with steatosis, necroinflammation and fibrosis.
    Arvaniti VA; Thomopoulos KC; Tsamandas A; Makri M; Psyrogiannis A; Vafiadis G; Assimakopoulos SF; Labropoulou-Karatza C
    Acta Gastroenterol Belg; 2008; 71(4):355-60. PubMed ID: 19317274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoadiponectinemia plays a crucial role in the development of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus independent of visceral adipose tissue.
    Yoneda M; Iwasaki T; Fujita K; Kirikoshi H; Inamori M; Nozaki Y; Maeyama S; Wada K; Saito S; Terauchi Y; Nakajima A
    Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S15-21. PubMed ID: 17331160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beyond insulin resistance in NASH: TNF-alpha or adiponectin?
    Hui JM; Hodge A; Farrell GC; Kench JG; Kriketos A; George J
    Hepatology; 2004 Jul; 40(1):46-54. PubMed ID: 15239085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adiponectin gene polymorphisms modulate acute adiponectin response to dietary fat: Possible pathogenetic role in NASH.
    Musso G; Gambino R; De Michieli F; Durazzo M; Pagano G; Cassader M
    Hepatology; 2008 Apr; 47(4):1167-77. PubMed ID: 18311774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of oxidative stress and inflammation by hepatic adiponectin receptor 2 in an animal model of nonalcoholic steatohepatitis.
    Matsunami T; Sato Y; Ariga S; Sato T; Kashimura H; Hasegawa Y; Yukawa M
    Int J Clin Exp Pathol; 2010 May; 3(5):472-81. PubMed ID: 20606728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic AdipoR2 signaling plays a protective role against progression of nonalcoholic steatohepatitis in mice.
    Tomita K; Oike Y; Teratani T; Taguchi T; Noguchi M; Suzuki T; Mizutani A; Yokoyama H; Irie R; Sumimoto H; Takayanagi A; Miyashita K; Akao M; Tabata M; Tamiya G; Ohkura T; Hibi T
    Hepatology; 2008 Aug; 48(2):458-73. PubMed ID: 18666257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum intercellular adhesion molecule-1 in patients with nonalcoholic steatohepatitis: comparison with alcoholic hepatitis.
    Ito S; Yukawa T; Uetake S; Yamauchi M
    Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S83-7. PubMed ID: 17331172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic expression of adiponectin receptors increases with non-alcoholic fatty liver disease progression in morbid obesity in correlation with glutathione peroxidase 1.
    Carazo A; León J; Casado J; Gila A; Delgado S; Martín A; Sanjuan L; Caballero T; Muñoz JA; Quiles R; Ruiz-Extremera A; Alcázar LM; Salmerón J
    Obes Surg; 2011 Apr; 21(4):492-500. PubMed ID: 21240660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired left ventricular mechanics in nonalcoholic fatty liver disease: a speckle-tracking echocardiography study.
    Karabay CY; Kocabay G; Kalayci A; Colak Y; Oduncu V; Akgun T; Kalkan S; Guler A; Kirma C
    Eur J Gastroenterol Hepatol; 2014 Mar; 26(3):325-31. PubMed ID: 24161963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH.
    Yoneda M; Mawatari H; Fujita K; Iida H; Yonemitsu K; Kato S; Takahashi H; Kirikoshi H; Inamori M; Nozaki Y; Abe Y; Kubota K; Saito S; Iwasaki T; Terauchi Y; Togo S; Maeyama S; Nakajima A
    J Gastroenterol; 2007 Jul; 42(7):573-82. PubMed ID: 17653654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.